Grameva (BSE 539120)₹76.60−4.96%Jute & Jute Products
In the Mar 2026 quarter (standalone), Grameva reported sales of ₹55.86 Cr, up 336.7% from Mar 2025, and net profit of ₹2.64 Cr, up 700.0% year on year. For the year to Mar 2026, sales were ₹82.94 Cr and net profit ₹3.03 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.61 | 5.39 | 9.40 | 18.08 | 10.79 | 12.44 | 5.52 | 12.79 | 7.16 | 7.34 | 12.61 | 55.86 |
| Expenses | 4.50 | 4.77 | 9.19 | 17.64 | 10.52 | 12.42 | 5.14 | 12.34 | 6.55 | 7.47 | 12.49 | 51.43 |
| Operating Profit | 0.09 | 0.60 | 0.17 | 0.34 | 0.22 | −0.05 | 0.36 | 0.40 | 0.58 | −0.18 | 0.06 | 4.16 |
| OPM % | 1.8% | 11.1% | 1.7% | 1.8% | 2.0% | −0.3% | 6.4% | 3.1% | 8.0% | −2.3% | 0.4% | 7.5% |
| Other Income | 0.07 | 0.00 | 0.00 | 0.03 | 0.10 | 0.20 | 0.15 | 0.29 | 0.26 | 0.23 | 0.23 | −0.03 |
| Interest | 0.12 | 0.12 | 0.09 | 0.25 | 0.14 | 0.15 | 0.19 | 0.30 | 0.20 | 0.23 | 0.09 | 0.27 |
| Depreciation | 0.05 | 0.09 | 0.08 | 0.09 | 0.09 | 0.10 | 0.10 | 0.09 | 0.10 | 0.11 | 0.10 | 0.15 |
| Profit before tax | 0.02 | 0.39 | 0.02 | 0.04 | 0.10 | −0.09 | 0.21 | 0.31 | 0.55 | −0.26 | 0.13 | 3.72 |
| Tax % | 0.0% | 27.5% | 0.0% | 40.0% | 27.2% | 0.0% | 27.3% | −10.0% | −20.4% | 111.1% | 16.7% | 29.2% |
| Net Profit | 0.02 | 0.31 | 0.02 | 0.04 | 0.09 | −0.09 | 0.17 | 0.33 | 0.67 | −0.58 | 0.10 | 2.64 |
| EPS (Rs) | 0.01 | 0.64 | 0.01 | 0.07 | 0.18 | −0.18 | 0.34 | 0.68 | 1.37 | −1.20 | 0.20 | 5.49 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.67 | 0.25 | 9.84 | 17.25 | 19.12 | 20.26 | 22.40 | 24.55 | 37.50 | 41.54 | 82.94 | 82.97 |
| Expenses | 0.63 | 0.23 | 9.44 | 16.72 | 18.29 | 19.87 | 21.81 | 24.17 | 36.10 | 40.43 | 77.89 | 77.94 |
| Operating Profit | 0.03 | 0.00 | 0.36 | 0.44 | 0.74 | 0.29 | 0.48 | 0.23 | 1.17 | 0.92 | 4.65 | 4.62 |
| OPM % | 3.1% | 0.0% | 3.6% | 2.5% | 3.9% | 1.4% | 2.1% | 0.9% | 3.1% | 2.2% | 5.6% | 5.6% |
| Other Income | 0.00 | 0.00 | 0.04 | 0.24 | 0.46 | 0.54 | 0.38 | 0.50 | 0.12 | 0.74 | 0.71 | 0.69 |
| Interest | 0.00 | 0.00 | 0.00 | 0.05 | 0.42 | 0.37 | 0.33 | 0.34 | 0.55 | 0.76 | 0.80 | 0.79 |
| Depreciation | 0.00 | 0.00 | 0.04 | 0.12 | 0.21 | 0.14 | 0.20 | 0.19 | 0.28 | 0.35 | 0.44 | 0.46 |
| Profit before tax | 0.03 | 0.00 | 0.34 | 0.50 | 0.58 | 0.31 | 0.36 | 0.19 | 0.47 | 0.56 | 4.11 | 4.14 |
| Tax % | 0.0% | — | 22.8% | −15.7% | 12.2% | 50.0% | 57.1% | 20.0% | 29.2% | 10.9% | 26.9% | — |
| Net Profit | 0.03 | 0.00 | 0.29 | 0.59 | 0.52 | 0.17 | 0.16 | 0.18 | 0.35 | 0.50 | 3.03 | 2.83 |
| EPS (Rs) | 0.09 | 0.00 | 0.57 | 1.22 | 1.07 | 0.34 | 0.32 | 0.36 | 0.72 | 1.03 | 6.30 | 5.86 |
| Dividend payout % | 0.0% | — | 0.0% | 0.0% | 14.7% | 0.0% | 0.0% | 0.0% | 282.3% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.60 | 2.61 | 2.61 | 4.79 | 4.79 | 4.79 | 4.81 | 4.80 | 4.79 | 4.79 | 4.79 | 4.79 |
| Reserves | 0.43 | 0.45 | 0.45 | 1.11 | 1.76 | 2.24 | 2.33 | 2.47 | 2.64 | 2.91 | 3.40 | 6.43 |
| Borrowings | 0.11 | 0.16 | 0.19 | 0.49 | 3.03 | 2.54 | 2.99 | 3.85 | 3.23 | 2.86 | 8.62 | 9.90 |
| Other Liabilities | 0.03 | 0.04 | 0.02 | 1.58 | 2.68 | 6.32 | 6.86 | 2.62 | 2.95 | 6.20 | 5.52 | 6.78 |
| Total Liabilities | 3.17 | 3.26 | 3.27 | 7.97 | 12.26 | 15.89 | 16.99 | 13.74 | 13.61 | 16.76 | 22.33 | 27.90 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.42 | 1.57 | 1.37 | 2.44 | 2.10 | 3.14 | 3.76 | 3.79 | 4.33 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 5.51 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Other Assets | 3.17 | 3.26 | 3.27 | 7.55 | 10.69 | 14.52 | 14.55 | 11.64 | 10.47 | 13.00 | 18.37 | 18.04 |
| Inventories | 0.72 | 2.82 | 3.01 | 1.12 | 0.32 | 2.51 | 3.60 | 3.40 | 3.15 | 4.03 | 4.49 | 1.79 |
| Trade receivables | 0.15 | 0.28 | 0.07 | 5.53 | 6.76 | 8.01 | 7.41 | 3.50 | 4.33 | 5.78 | 3.46 | 13.67 |
| Cash & equivalents | 0.06 | 0.06 | 0.03 | 0.48 | 0.25 | 0.83 | 0.16 | 1.11 | 0.14 | 0.19 | 0.14 | 1.72 |
| Total Assets | 3.17 | 3.26 | 3.27 | 7.97 | 12.26 | 15.89 | 16.99 | 13.74 | 13.61 | 16.76 | 22.33 | 27.90 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.81 | −2.20 | 0.04 | −2.02 | −1.69 | 1.20 | 0.20 | 0.23 | 0.92 | 1.40 | 2.08 | −2.62 |
| Cash from investing activity | 0.47 | 2.17 | −0.11 | −0.44 | −1.07 | 0.30 | −0.90 | 0.20 | −0.98 | −0.89 | −7.11 | 4.04 |
| Cash from financing activity | 0.32 | 0.03 | 0.05 | 2.87 | 2.50 | −0.91 | 0.00 | 0.58 | −0.94 | −0.47 | 4.94 | 0.14 |
| Net cash flow | −0.04 | 0.00 | −0.04 | 0.45 | −0.21 | 0.59 | −0.69 | 0.99 | −0.97 | 0.06 | −0.07 | 1.57 |
| Capex | 0.00 | 0.00 | 0.00 | 0.45 | 1.26 | 0.00 | 1.18 | 0.00 | 1.21 | 0.88 | 0.52 | 6.29 |
| Free cash flow | −0.79 | −2.20 | 0.04 | −2.48 | −2.96 | 1.20 | −1.01 | 0.38 | −0.30 | 0.51 | −5.65 | −8.93 |
| CFO / OP % | — | −10,950.1% | — | −563.1% | −370.0% | 177.0% | 89.0% | 51.0% | 482.0% | 127.9% | 240.0% | −48.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 110 | 160 | 122 | 206 | 144 | 154 | 134 | 57 | 65 | 57 | 31 | 60 |
| Inventory days | 761 | 1,986 | 9,186 | 46 | 8 | 56 | 75 | 64 | 51 | 42 | 42 | 9 |
| Days payable | 0 | 0 | 0 | 53 | 47 | 135 | 118 | 29 | 38 | 56 | 44 | 25 |
| Cash conversion cycle | 871 | 2,147 | 9,308 | 199 | 105 | 76 | 91 | 92 | 77 | 43 | 29 | 44 |
| Working capital days | 634 | 1,731 | 4,715 | 190 | 82 | 73 | 86 | 73 | 72 | 45 | 53 | 11 |
| ROCE % | 0.3% | 0.6% | 0.0% | 7.3% | 6.9% | 10.2% | 6.9% | 6.3% | 4.9% | 9.6% | 9.5% | 25.9% |
For the Mar 2026 quarter, Grameva reported sales of ₹55.86 Cr, up 336.7% year on year and net profit of ₹2.64 Cr, up 700.0% year on year. The operating margin was 7.5%.
Grameva's sales for the year to Mar 2026 were ₹82.94 Cr; over the last twelve months they were ₹82.97 Cr.
Net profit for the year to Mar 2026 was ₹3.03 Cr, and ₹2.83 Cr over the last twelve months. Earnings per share over the same trailing period were ₹5.86.
Grameva reported borrowings of ₹9.90 Cr at Mar 2026, against cash and equivalents of ₹1.72 Cr.
Cash from operations was −₹2.62 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹8.93 Cr.